Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.004 Å; R factor = 0.063; wR factor = 0.132; data-to-parameter ratio = 16.5.
In the title molecule, C 20 H 19 N 3 O 4 S, the heterocyclic thiazine ring adopts a half-chair conformation with the S and N atoms displaced by 0.492 (6) and 0.199 (6) Å , respectively, on opposite sides from the mean plane formed by the remaining ring atoms. The ethanone group lies at an angle of 9.4 (2) with respect to the benzene ring, which lies almost perpendicular to the pyrazole ring, with a dihedral between the two planes of 78.07 (9) . In the crystal, molecules are linked by weak C-HÁ Á ÁO hydrogen bonds. Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) x; y À 1; z; (ii) x þ 1 2 ; Ày þ 1 2 ; z À 1 2 ; (iii) Àx þ 3 2 ; y þ 1 2 ; Àz þ 1 2 ; (iv) Àx þ 1; Ày þ 1; Àz.
Related literature
Data collection: COLLECT (Hooft, 1998); cell refinement: DENZO (Otwinowski & Minor, 1997) ; data reduction: SCALE-PACK (Otwinowski & Minor, 1997); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997); software used to prepare material for publication: SHELXL97. (3, [1,2]benzothiazin-2-yl)-1-(4methoxyphenyl)ethanone S. Aslam, H. L. Siddiqui, M. Ahmad, T. Hussain and M. Parvez
2-

Comment
Both benzothiazines and pyrazoles are known as versatile biologically active heterocyclic nuclei. Pyrazoles are found to be cytotoxic agents (Ciciani et al., 2008 ), anti-tumor (Farag et al., 2008 ), anti-malarial (Cunico et al., 2006 , etc. In continuation to our research interests in biologically active molecules (Ahmad et al., 2010) , we have fused both of these heterocycles and herein report the synthesis and crystal structure of the title compound.
The bond distances and angles in the title compound ( Fig. 1 ) agree very well with the corresponding bond distances and angles reported in closely related compounds (Siddiqui et al., 2008) . The heterocyclic thiazine ring adopts a half chair conformation with the atoms S1 and N1 displaced by 0.492 (5) and 0.199 (5) Å, respectively, on the opposite sides from the mean plane formed by the remaining ring atoms. The ethanone group O3/C12/C13/C14 is oriented at 9.4 (2)° with the benzene ring (C14-C19) which forms a dihedral angle 78.07 (9)° with the pyrazolyl ring (N2/N3/C7/C8/C10). The crystal packing (Fig. 2) is stabilized by weak intermolecular C-H···O hydrogen bonds (see, Table 1 ).
Experimental
Equimolar quantities of 3,4-dimethyl-2,4-dihydropyrazolo[4,3-c][1,2] benzothiazine 5,5-dioxide (1.0 g, 4.01 mmol) and p-methoxyphenacyl bromide (0.92 g, 4.01 mmol) were dissolved in acetonitrile (20 ml) followed by the addition of equimolar K 2 CO 3 (0.55 g, 4.01 mmol). The mixture was subjected to reflux for 7 h. The completion of reaction was monitored with the help of TLC. The precipitates of the title compound formed were collected and washed with methanol. The crystals suitable for X-ray crystallographic analysis were grown from a solution of CHCl 3 :MeOH in 1:1 ratio.
Refinement
All H atoms were positioned geometrically and refined using a riding model, with C-H = 0.95, 0.98 and 0.99 Å, for aryl, methyl and methylene H-atoms, respectively. The U iso (H) were allowed at 1.5U eq (C methyl) or 1.2U eq (C non-methyl). Fig. 1 . The molecular structure of the title compound with the atom numbering scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms are presented as small spheres of arbitrary radius. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Figures
(i) x, y + 1, z; (ii) -x + 1/2, y + 1/2, -z + 1/2; (iii) -x + 3/2, y + 1/2, -z + 1/ 2; (iv) x -1/2, y -1/2, z + 1/2.] 2-(3,4-Dimethyl-5,5-dioxo-2H,4H-pyrazolo[4,3-c][1,2]benzothiazin-2-yl)-1-(4-methoxyphenyl)ethanone
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq S1 0.74841 (6) Geometric parameters (Å, °) S1-O1 1.429 (2) C8-C10 1.380 (4) S1-O2 1.439 (2) C9-H9A 0.9800 S1-N1 1.650 (3) C9-H9B 0.9800 S1-C5 1.400 (4) C20-H20A 0.9800 C6-C7 1.457 (4) C20-H20B 0.9800 C7-C8 1.407 (4) C20-H20C 0.9800 O1-S1-O2 118.68 (14) H9B-C9-H9C 109.5 O1-S1-N1 108.34 (13) N3-C10-C8 104.5 (2) O2-S1-N1 106.97 (13) N3-C10-C11 124.4 (3) O1-S1-C5 109.83 (13) C8-C10-C11 131. C11-H11C···O2 iv 0.98 2.56 3.498 (4) 161.
C12-H12B···O2 iv 0.99 2.33 3.309 (4) 170.
Symmetry codes: (i) x, y−1, z; (ii) x+1/2, −y+1/2, z−1/2; (iii) −x+3/2, y+1/2, −z+1/2; (iv) −x+1, −y+1, −z.
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